Macrolide-lincosamide-streptogramin B resistance in Clostridium difficile is mostly due to the ermB resistance determinant. Here, we describe a sensitive and rapid molecular method to detect ermB in C. difficile to contribute to the wider epidemiological study. Five sets of loop-mediated isothermal amplification (LAMP) primers were designed and optimized for rapid detection of ermB. The specificity and sensitivity of the primers for ermB were detected, and the ermB LAMP assay was compared to conventional PCR with 80 clinical isolates of C. difficile. Real-time monitoring of turbidity and chromogenic reaction were used to determine negative and positive results. A total of 26 pathogenic bacterial strains of different species were found to be negative for ermB, which indicated the high specificity of the primers. ermB was detected in 78.8 % (63/80) of the clinical isolates by both LAMP and conventional PCR. The detection limit of LAMP was 36.1 pg DNA ml 21 and its sensitivity was 10-fold greater than that of conventional PCR. This study is the first report regarding the development and application of the LAMP assay for detection of the ermB gene in C. difficile strains. The developed LAMP method is sensitive, specific and provides a user-friendly visual approach for the rapid detection of ermB-bearing C. difficile.
INTRODUCTION
Clostridium difficile is a causative agent of antibiotic-associated diarrhoea and pseudomembranous colitis, usually as a consequence of antimicrobial therapy. During the last few decades, C. difficile infection (CDI) has become more severe, more recurrent, more resistant to antibiotics and more refractory to standard treatment, which poses a significant burden on patients, healthcare systems and society in general. Estimates suggest that the annual costs for management of CDI amount to more than $3 billion in the USA and J3 billion in Europe (Bouza, 2012; McGlone et al., 2012) . Major risk factors for CDI include hospitalization, advanced age and antibiotic exposure, the latter including clindamycin and erythromycin (Aziz et al., 2001; Gerding, 1989; Kelly et al., 1994; Slimings & Riley, 2014) . The majority of epidemic isolates are resistant to clindamycin, erythromycin, broad-spectrum cephalosporins and fluoroquinolones (Johnson et al., 1999; Spigaglia et al., 2011; Slimings & Riley, 2014) . Thus, resistance to clindamycin and erythromycin, two antibiotics of the macrolidelincosamide-streptogramin B (MLSB) group, would further increase the risk of CDI.
In C. difficile, resistance to the MLSB group of antibiotics is mainly encoded by the ermB resistance determinant. The ermB gene encodes a 23S rRNA methyltransferase that modifies the target site for the antibiotic and is located on a specific mobilizable non-conjugative element, Tn5398 (Farrow et al., 2001) . However, the ermB gene is located on elements other than Tn5398 in the majority of clinical isolates. In total, 17 genetic organizations of such elements were identified by a PCR-mapping assay based on the sequence of Tn5398, and named E1 to E17 (Farrow et al., 2001; Spigaglia et al., 2005 Spigaglia et al., , 2011 . Considering the emergence of MLSB-resistant C. difficile, a sensitive and specific method for detection of ermB is needed for the wider epidemiological study of C. difficile and will contribute to reducing CDI outbreaks.
Recently, a number of molecular methods to identify and quantify the ermB gene have been described, such as various versions of PCR [e.g. conventional PCR (Spigaglia et al., 2007) , real-time quantitative PCR (qPCR) (Belén Fló rez et al., 2014) and multiplex PCR (Martineau et al., 2000) ]. While these assays permit rapid, sensitive and specific diagnosis, the equipment required is rather sophisticated and consumables are expensive. In addition, the Taq DNA polymerase used in PCR can be blocked by inhibitors present in crude biological fluids and substances (de Franchis et al., 1988) . Thus, another rapid, sensitive and cost-efficient assay is needed to complement current PCR methods. Loop-mediated isothermal amplification (LAMP) assays rely on auto-cycling strand displacement DNA synthesis in the presence of Bst DNA polymerase under isothermal conditions within 60 min (Notomi et al., 2000; Ushikubo, 2004) . In contrast to Taq DNA polymerase used in PCR, the Bst DNA polymerase is resistant to inhibitors present in crude biological samples (Kaneko et al., 2007) . As four or six specific primers that recognize six or eight distinct sequences on the target DNA are required, LAMP has been shown to amplify target DNA with high specificity and is widely used in the clinical diagnosis of epidemic bacteria Knight et al., 2014) , viruses (Poon et al., 2004; Curtis et al., 2014) , parasites (Li et al., 2012; Ni et al., 2014) and fetal sex identification (Fu et al., 2011) , as well as detection of the hypervirulent strain and toxin types of C. difficile (Kato et al., 2005; Norén et al., 2011; Boyanton et al., 2012) . In the current study, five sets of LAMP primers were designed and the assay was optimized for detection of ermB. The specificity and sensitivity of the ermB primers were detected, and the ermB LAMP assay was compared to conventional PCR with 80 clinical isolates of C. difficile.
METHODS
Bacterial strains. A total of 27 pathogenic bacterial strains of different species were used to establish the LAMP assays, and their sources are listed in Table 1 . C. difficile VPI10463 carrying ermB with the typical antimicrobial resistance was chosen as the positive control. The strain's ermB gene was validated by PCR-based sequencing, and the sequence (GenBank accession number: JN607214.1) showed 100 % identity to those of previously reported ermB sequences (see Fig. S1 , available in the online Supplementary Material). All of the toxigenic C. difficile clinical isolates were cultured from stool specimens on selective cycloserine-cefoxitin-fructose agar plates (Oxoid). Fresh stool specimens from hospitalized patients suspected of CDI were consecutively collected from October 2012 to May 2014 in Nanfang Hospital, Southern Medical University, Guangzhou, China. The identification of C. difficile toxigenic isolates depended on their typical morphology on agar plates, Gram staining and PCR for the tcdA (Kato et al., 1991) , tcdB (Kato et al., 1999) , cdtA (Stubbs et al., 2000) , cdtB (Stubbs et al., 2000) and tetM (Schmidt et al., 2007) genes as described previously.
DNA extraction. In order to determine the specificity and sensitivity of the LAMP reactions under real conditions, genomic DNA was extracted from C. difficile VPI10463 and purified by the Wizard Genomic DNA purification kit (Promega). The purified genomic DNA was serially diluted 10-fold in distilled water from 361 ng ml 21 to 0.000361 pg ml 21 . Genomic DNA of 26 pathogenic bacterial strains and C. difficile from clinical isolates were extracted by using the TIANamp Bacteria DNA kit (Tiangeng) according to the manufacturer's instructions. DNA was stored at 220 uC until it was used as a template in the LAMP and PCRs.
Primer design. Five sets of LAMP primers were designed to target six or eight distinct sequences downloaded from the NCBI GenBank database (accession number: AM180355.1). Primer Explorer V4 software [http://primerexplorer.jp] was chosen to design the primers ( Table 2 ). The two loop primers [forward loop primer (LF) and backward loop primer (LB)] contributed to accelerating the amplification reaction. The FIP and BIP primers were linked by a four-thymidine spacer (TTTT). A conventional ermB PCR assay was conducted by the primer sets E5 and E6 as previously reported (Spigaglia et al., 2007) . All primers were synthesized by Sangon Biotech. Detection of LAMP products. Two methods, the real-time monitoring of turbidity and the chromogenic reaction with calcein/Mn 2+ complex, were used to detect LAMP products. For monitoring of turbidity, a Loopamp turbidimeter (LA-320c; Eiken Chemical Company) served to monitor the real-time amplification by measuring the optical density (l 650nm ) every 6 s. The changes in turbidity were caused by the amplification by-product Mg 2 P 2 O 7 (a white precipitate). For visual inspection, 1 ml of calcein (Fluorescent Detection Reagent; Eiken Chemical Company) was added to the 25 ml in the LAMP tubes once all the reaction mixtures were prepared. Calcein, a metal indicator, by adding manganous ions will form an insoluble salt with the pyrophosphate during the LAMP reaction. This will quench the reaction by forming a complex with calcein, thus making the reaction mixture fluoresce (Tomita et al., 2008) . When the colour changed from orange to green, the LAMP reaction was regarded as positive. When the colour failed to change and remained orange, the reaction was deemed negative. The colour change could be observed by the naked eye under natural light or under UV light at 365 nm.
PCR detection. The PCR conditions used for amplification were those described previously (Spigaglia et al., 2007) . The PCR-amplified products were analysed by 2 % agarose gel (Amresco) electrophoresis and stained with ethidium bromide. Images were documented using a Bio-Rad Gel Doc EQ Imaging System.
RESULTS

Optimal primers for ermB LAMP reaction
Five sets of primers were designed to detect ermB. All turbidity curves started to rise 14 min after the beginning of the reaction under the same conditions, which meant that all primer sets amplified the target gene. The ermB118 primer set (Table 2 ) amplified the target sequence faster than the other primer sets; therefore, it was selected as the most appropriate primer set for ermB detection by LAMP (Fig. 1) . From our data, it was concluded that the reaction time of the ermB118 primer set with loop primers (LB and LF) was approximately one-half that of the ermB5 primer set without loop primers, which is consistent with a previous report (Nagamine et al., 2002) .
Appropriate temperature for ermB LAMP reaction
To determine the most appropriate temperature of the LAMP reaction, different temperatures were tested in the range 58-65 uC at 1 uC intervals using the ermB118 primer set. As demonstrated in Fig. 2 , 62-65 uC was the most suitable reaction temperature range. Finally, 62 uC was chosen as the most appropriate temperature because it achieved the fastest amplification of the target sequence.
Specificity of ermB LAMP reaction
The C. difficile VPI10463 strain carrying ermB as positive control was used to estimate the specificity of the LAMP reaction for detecting ermB. Twenty-six pathogenic bacterial strains of different species without ermB, and distilled water, were designed as negative controls. As shown in Fig. 3(a) , turbidity was increased in C. difficile VPI10463, while no changes in turbidity were recorded for other Five sets of primers amplified ermB under the same conditions. Turbidity was monitored to measure the optical density by a Loopamp real-time turbidimeter at 650 nm every 6 s. Assays with the ermB118 primer set were performed with loop primers (LB and LF); assays with the ermB5 primer set were performed without loop primers; assays with the other sets were performed with LB.
strains. These results indicated high specificity of the primers. Chromogenic reactions were used for direct visual inspection (Fig. 3b) . Before the LAMP reaction, 1 ml of calcein/Mn 2+ complex was added to 25 ml of the LAMP reaction mixture. After the reaction finished, the result was deemed positive if the colour changed to green, otherwise it was negative. The results of the chromogenic reactions were identical to those obtained from turbiditybased detection experiments.
Sensitivity of ermB LAMP reaction
To determine the LAMP assay detection limit, genomic DNA was extracted from C. difficile VPI10463 using the Wizard Genomic DNA purification kit, and then serially diluted 10-fold from 361 ng ml 21 to 0.000361 pg ml
21
. Distilled water was used as a negative control. As shown in Fig. 4(a) , the detection limit of the LAMP reaction for ermB was established as 36.1 pg ml
. Visual inspection using a fluorescent detection reagent was chosen to detect the LAMP assay limit (Fig. 4b) . The result from the realtime monitoring of turbidity was the same as the chromogenic reaction. Furthermore, PCR using primers E5 and E6 with the same concentration of C. difficile VPI10463 DNA was also evaluated. The detection limit of PCR was 361 pg ml 21 (Fig. 4c) , which was 10-fold lower than that of the LAMP reaction.
Evaluation of the assay with clinical isolates
A total of 80 toxigenic C. difficile isolates were collected between October 2012 and May 2014 in Nanfang Hospital, and further analysed for their toxin types and resistance genes (Table 3) 
DISCUSSION
This study is the first report on the application of a LAMP assay for detection of the ermB gene in C. difficile. From our study, the reaction time of the LAMP with loop primers (LB and LF) was approximately one-half that of the original LAMP method without loop primers (Nagamine et al., 2002) , thus confirming that the two loop primers contributed to accelerating the amplification reaction. The result of ermB detection in 80 toxigenic C. difficile isolates by the LAMP assay was completely consistent with conventional PCR, suggesting that these two methods are comparable. However, the sensitivity of the LAMP assay was shown to be 10-fold greater than that of conventional PCR, suggesting that there may be an important benefit in using this more cost-effective assay in countries with low economic growth. Besides, the positive rate of ermB dramatically reached 78.8 %, which is higher than other reports from China (58.3-69.1 %) (Huang et al., 2010; Dong et al., 2013) . This may be explained by the regional difference in C. difficile populations. In order to better understand ermB prevalence, we are now working on a larger-scale screening by LAMP; 93.8 % of the isolates were positive for tetM in this study, which is similar to a previous report (Huang et al., 2010) . These preliminary results suggest that strains of C. difficile that carry ermB or tetM genes may be common aetiological agents of CDI in China.
Recently, a number of molecular assays to detect ermB have been described which include various versions of PCR [e.g. conventional PCR (Spigaglia et al., 2007) , realtime qPCR (Belén Fló rez et al., 2014) and multiplex PCR (Martineau et al., 2000) ]. These various versions of PCR are conducted under time-consuming, temperature-cycling conditions, which require high-precision PCR instruments. Compared with PCR, the LAMP reaction requires a generally shorter time and is less labour-intensive: the reaction time is usually less than one hour and the reaction is run under isothermal conditions in which a temperaturecontrolled water bath or another heat-stable device is sufficient. In addition, the LAMP reaction is more specific than . Different temperatures from 58 8C to 65 8C at 1 8C intervals were observed to determine the most appropriate for the ermB LAMP reaction using the ermB118 primer set. Turbidity was monitored by a Loopamp real-time turbidimeter at 650 nm every 6 s.
PCR and multiplex PCR because the LAMP primers are designed to target six or eight distinct sequences while PCR primers are designed to target only two distinct sequences, and multiplex PCR may show cross-reactivity with other species (Wang et al., 2014) . The LAMP assay is more sensitive than PCR and multiplex PCR (Wang et al., 2014) since it can amplify amounts of DNA as small as 10 9 copies in less than an hour (Notomi et al., 2000) and its detection limit is at least 10-fold greater than that of a conventional PCR assay (Li et al., 2012) . Furthermore, LAMP is more stable than PCR and qPCR (Francois et al., 2011) . As the presence of exogenous DNA and inhibitors in clinical samples has less impact on the sensitivity of LAMP than PCR, DNA purification from samples for LAMP detection may be omitted (de Franchis et al., 1988 , Kaneko et al., 2007 . A cold chain is essential when preparing the master mix for PCR, while it is not mandatary in the case of LAMP. With the help of a calcein/Mn 2+ complex, LAMP has become an approach to directly visualizing the reaction, while PCR still needs complex instruments to determine the results. qPCR depends on fluorescence probes to obtain either qualitative or quantitative results, while LAMP can also be qualitative and quantitative and relies on DNA synthesis by auto-cycling strand displacement (Mori et al., 2004) . However, the sensitivity of LAMP is slightly lower than that of qPCR (Anthony Johnson et al., 2014; Wang et al., 2013) . Considering that qPCR is a time-consuming procedure that requires expensive and relatively complicated equipment, including a thermal cycler with realtime monitoring and data-analysis systems, LAMP still has clear advantages over qPCR in terms of practicality.
In conclusion, we feel that LAMP-based assays would be superior to various versions of PCR for rapid detection of ermB in inspection and quarantine departments in a hospital, especially for routine clinical diagnostic and infection control purposes.
Although many advantages of the LAMP assay have been reported, there is still a drawback of the current technique. Because of the assay's high sensitivity, the current technique is susceptible to relatively high false-positive rates.
To avoid contamination, strict spatial separation of reagent preparation from the testing area is necessary. In the current study, a sealing agent was added to the reaction tube after all the reaction mixture had been prepared, in order to prevent contamination.
This study did not show the correlation between the presence of the ermB gene and phenotypic MLSB antimicrobial resistance, which may have made this assay more clinically relevant. Despite that, the developed LAMP method is sensitive, specific and provides a user-friendly visual method for the rapid detection of ermB-bearing C. difficile strains. The current LAMP technique will contribute to the epidemiological study of C. difficile and the reduction of CDI outbreaks. China (grant no. NCET-10-0091). We are indebted to the Institute of Disease Control and Prevention, Academy of Military Medical Sciences for providing technical assistance and helpful discussions. The authors have no conflicts of interest to declare. The Ethical Committee of Southern Medical University has approved the current study. Informed consent had been signed by the hospitalized patient suspected of CDI. Rapid detection of ermB gene in Clostridium difficile
